KAREX BERHAD

KLSE (MYR): KAREX (5247)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.835

Today's Change

-0.01 (1.18%)

Day's Change

0.835 - 0.845

Trading Volume

410,300

Financial

Show?
Last 10 FY Result
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 511,902 518,792 532,066 421,642 419,816 395,067 379,924 408,014 361,452 343,617 298,094 219,927 10.30%
PBT 34,276 31,246 15,131 -6,488 -534 5,647 3,804 14,278 37,049 79,350 73,282 41,541 -10.60%
Tax -9,473 -8,704 -4,653 297 680 -2,328 -747 -4,090 -8,243 -12,927 -13,552 -6,956 -4.36%
NP 24,802 22,542 10,478 -6,191 146 3,319 3,057 10,188 28,806 66,423 59,730 34,585 -12.41%
-
NP to SH 24,802 22,542 10,478 -6,191 -1,020 228 2,533 10,103 27,946 66,685 59,553 34,585 -12.41%
-
Tax Rate 27.64% 27.86% 30.75% - - 41.23% 19.64% 28.65% 22.25% 16.29% 18.49% 16.74% -
Total Cost 487,100 496,250 521,588 427,833 419,670 391,748 376,867 397,826 332,646 277,194 238,364 185,342 12.17%
-
Net Worth 484,591 484,591 474,057 452,988 463,522 481,139 491,163 481,139 501,187 481,139 406,758 130,733 15.37%
Dividend
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 14,046 15,801 5,267 - - - 5,011 10,023 - - - - -
Div Payout % 56.63% 70.10% 50.27% - - - 197.86% 99.22% - - - - -
Equity
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 484,591 484,591 474,057 452,988 463,522 481,139 491,163 481,139 501,187 481,139 406,758 130,733 15.37%
NOSH 1,053,460 1,053,460 1,053,460 1,053,460 1,053,460 1,002,375 1,002,375 1,002,375 1,002,375 1,002,375 625,782 237,697 17.97%
Ratio Analysis
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 4.85% 4.35% 1.97% -1.47% 0.03% 0.84% 0.80% 2.50% 7.97% 19.33% 20.04% 15.73% -
ROE 5.12% 4.65% 2.21% -1.37% -0.22% 0.05% 0.52% 2.10% 5.58% 13.86% 14.64% 26.45% -
Per Share
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 48.59 49.25 50.51 40.02 39.85 39.41 37.90 40.70 36.06 34.28 47.64 92.52 -6.50%
EPS 2.36 2.14 0.99 -0.59 -0.10 0.02 0.25 1.01 2.79 6.65 6.34 14.55 -25.80%
DPS 1.33 1.50 0.50 0.00 0.00 0.00 0.50 1.00 0.00 0.00 0.00 0.00 -
NAPS 0.46 0.46 0.45 0.43 0.44 0.48 0.49 0.48 0.50 0.48 0.65 0.55 -2.20%
Adjusted Per Share Value based on latest NOSH - 1,053,460
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 48.59 49.25 50.51 40.02 39.85 37.50 36.06 38.73 34.31 32.62 28.30 20.88 10.30%
EPS 2.36 2.14 0.99 -0.59 -0.10 0.02 0.24 0.96 2.65 6.33 5.65 3.28 -12.45%
DPS 1.33 1.50 0.50 0.00 0.00 0.00 0.48 0.95 0.00 0.00 0.00 0.00 -
NAPS 0.46 0.46 0.45 0.43 0.44 0.4567 0.4662 0.4567 0.4758 0.4567 0.3861 0.1241 15.37%
Price Multiplier on Financial Quarter End Date
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 29/03/24 29/03/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 0.795 0.795 0.57 0.37 0.53 0.485 0.545 0.82 1.70 2.41 3.07 3.00 -
P/RPS 1.64 1.61 1.13 0.92 1.33 1.23 1.44 2.01 4.71 7.03 6.44 3.24 -11.03%
P/EPS 33.77 37.15 57.31 -62.96 -547.39 2,132.25 215.67 81.36 60.98 36.23 32.26 20.62 12.02%
EY 2.96 2.69 1.74 -1.59 -0.18 0.05 0.46 1.23 1.64 2.76 3.10 4.85 -10.75%
DY 1.68 1.89 0.88 0.00 0.00 0.00 0.92 1.22 0.00 0.00 0.00 0.00 -
P/NAPS 1.73 1.73 1.27 0.86 1.20 1.01 1.11 1.71 3.40 5.02 4.72 5.45 -14.93%
Price Multiplier on Announcement Date
AQR T4Q 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 21/05/24 21/05/24 28/08/23 29/08/22 29/09/21 24/08/20 28/08/19 28/08/18 29/08/17 30/08/16 25/08/15 22/08/14 -
Price 0.86 0.86 0.625 0.36 0.445 1.07 0.495 0.735 1.46 2.42 3.22 2.99 -
P/RPS 1.77 1.75 1.24 0.90 1.12 2.71 1.31 1.81 4.05 7.06 6.76 3.23 -10.08%
P/EPS 36.53 40.19 62.84 -61.26 -459.60 4,704.13 195.88 72.92 52.37 36.38 33.84 20.55 13.21%
EY 2.74 2.49 1.59 -1.63 -0.22 0.02 0.51 1.37 1.91 2.75 2.96 4.87 -11.68%
DY 1.55 1.74 0.80 0.00 0.00 0.00 1.01 1.36 0.00 0.00 0.00 0.00 -
P/NAPS 1.87 1.87 1.39 0.84 1.01 2.23 1.01 1.53 2.92 5.04 4.95 5.44 -14.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
32 people like this. Showing 50 of 11,890 comments

xiaoeh

Why Karex so strong ha? From $0.565shoot up to$0.650 within 2 weeks time?
Any news?

2023-11-20 18:10

ChloeTai

@xiaoeh, all glove counters are turning around. From negative earnings to positive earnings. Karex is following the gloves stocks. The 1st quarter results will be released next Monday. Expected target price is RM0.72.

2023-11-20 18:47

xiaoeh

Oic...
Thanks Chloe

2023-11-20 19:25

ChloeTai

Still manage to turn from -0.005 to +0.010 and closed at RM0.705. The AGM and 1st quarter results are on next Monday (27 Nov 2023). The target price still maintains at RM0.72.

2023-11-21 17:04

ChloeTai

By the end of the first half of the financial year 2024 (28 Feb 2024), the FDA (Food and Drug Administration) of US should have approved the new 001 condoms to be exported to US. The price of Karex will move north.

2023-11-21 17:08

ChloeTai

Sold all at RM0.690 and RM0.685. Got to follow the bears. I shifted to poultry counter LHI (Lay Hong International).

2023-11-22 19:13

xiaoeh

Good exit point in technical term Chloe.
Lay Hong Bhd bro.

2023-11-22 22:09

Tryingtogetrich

001 condoms are by karex? I thought there are by Okamoto. One condom released a Graphene condom 1 month ago is US

2023-11-24 15:38

ChloeTai

Very good 1st quarter results. Next Monday should rebound with high volume.

2023-11-24 18:59

Ayong21

Don't forget to go supermarket to buy couple more to support.

2023-11-24 23:43

xiaoeh

Posted by xiaoeh > 4 days ago | Report Abuse
Good exit point in technical term Chloe.

Walao...
my technical got a lot of rooms to improve

2023-11-27 21:36

cheoky

won big tender?

2023-12-03 22:13

GalGadot

Dropped again....hahaaa

2024-01-03 17:18

TiffanixLVxHermes

in my watchlist
still expensive to accumulate
waiting @ 0.60-0.65 :)

2024-01-19 12:31

ocbc

Bought it , AGM got free gift

2024-01-29 10:49

speakup

Condom lah

2024-01-29 12:43

speakup

Young man young woman like Karex bcoz can get free condom at AGM

2024-01-29 12:44

ocbc

😆

2024-01-29 13:31

ChloeTai

I went in today (2 Feb 2024). There is nothing much that I could do now. Just wait until end of February to see whether its quarter results is good enough or not. Bears are in full control now.

2024-02-02 16:02

ChloeTai

From a sleepy counter, become an active counter. Don't know what to expect.

2024-02-02 16:18

ChloeTai

Went down to as low as RM0.76, can manipulate to close at RM0.78.

2024-02-02 16:55

ChloeTai

The long tail below the body is indicative of sellers trying to push the price down by a significant amount but the buyers manage to push it back up. The buyers do this to show a definitive buying strength which will lead to an increase in price, going forward.

2024-02-03 20:48

ChloeTai

Kenanga's target price suddenly change from RM0.78 to RM1.00.

2024-02-05 11:58

speakup

Karex biz improve? More ppl f-a-r-k-i-n-g?

2024-02-05 21:22

TiffanixLVxHermes

wasted
look for cheap now even more expensive
good stuff won't get cheap
it happened many times 😂

2024-02-06 15:24

ChloeTai

KAREX is riding on the strong growth in the condom industry, focusing on high-margin products which will take its profitability to a higher level. It is penetrating high-growth markets with premium offerings backed by innovation and strict compliance with international standards. We project its earnings to double in FY24, followed by another 88% surge in FY25. We initial coverage on KAREX with an OUTPERFORM rating and a TP of RM1.00.

Kenanga Research

2024-02-13 18:23

ChloeTai

Read and listen to the words from Karex CEO. "Karex pivots beyond latex condoms". Results have been better quarter over quarter for 5 consecutive quarters. He said 26 Feb 2024 will also be better than the previous quarter. New products are lubricant and gloves.

2024-02-14 14:36

ChloeTai

The blog is at above.

2024-02-14 14:37

ChloeTai

Please understand that RM0.87 at this moment is not Karex all time high. Its all time high was RM3.10 on 11.3.2016. It is unlike Sunway, MBMR, HUMEIND, etc.

2024-02-14 15:27

Intelligentinvest

https://www.bfm.my/podcast/morning-run/the-breakfast-grille/karex-2024-condom-lubricant-glove-manufacturer-demand

2024-02-15 14:41

ChloeTai

Still thinking very hard whether or not I should bet on Karex next Monday, with its 2nd quarter results after 5 pm. Now 0.835 and the highest 0.87.

2024-02-24 00:28

ChloeTai

Very, very good 2nd quarter results:

PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 2nd quarter FY2023: RM2,025 million, which is an increased of 262% YoY]

PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 1st quarter FY2024: RM5,256 million, which is an increased of 39% QoQ]

Hopefully, the operator will help to break the 52-week ATH of RM0.87, starting 27 Feb 2024

2024-02-26 17:26

cheoky

buy one nasi lemak flavor condom and use tonight. support local manufacturer

2024-02-26 22:11

wallstreetrookieNEW

The heyday of being the sole and top condom manufacturer in Malaysia is over for Karex Bhd. I used to own a significant number of Karex shares, but it saddens me that the management has failed to turn the company around even after many years. I don't believe Karex will recover to its previous highs

2024-02-28 19:25

wallstreetrookieNEW

Agree with Kenanga's analyst with regards to the emphasis on improving margins by the company. However, the focus on premium products is not really feasible cause condom users do not place much importance on the actual quality of the products compared to other consumer staples.
There is no way for the company to bring the sales volume/total sales back to 2016 levels because the competition within the condom market is surging. Despite the recent introduction of abortion laws in the US, there isn't any significant uptick in sales for the US market which is a bit disappointing.

However, there still remains a few tailwinds for the condom market and near-term catalysts for Karex. Such as weaker Ringgit, and the stabilisation of raw material/labour cost. And the diversification/venture into gloves and lubricant products, on top of the company's healthy balance sheet.

My mid-term PT is about RM0.90

2024-02-28 19:34

Diving

不管怎样看都觉得股价会升

可是怎么就是一直升不上去？
跌跌不休？

2024-02-29 00:08

investor2011

@Diving 现在生活压力大，环境污染-想生都生不出，还要用套套？

2024-03-06 07:28

pang72

Consolidation shall finished..
$1.06 kenanga target coming..
KAREX is the largest condom Mfg in the world..
It need to reflect its strength but not below $1 penny world class

2024-03-28 15:16

pang72

Steady condom

2024-03-29 16:49

pang72

Everyone need you every night mah...
How can you so cheap

2024-03-29 16:50

pang72

Yes! Uptrend continue

2024-04-03 17:52

pang72

Lailiao huuu

2024-04-04 14:52

pang72

84.5c wei

2024-04-04 14:52

pang72

87c liao... Wei...

2024-04-05 17:51

s466466

90c....

2024-04-08 09:37

Bernice Yap

1 days show

2024-04-09 11:34

mamakspecial

s#x wont stop..but making baby is stopping around the world...lol..

2024-04-15 15:31

ChekHupCoffee

US tariff China condom?

2 months ago

kritikos

this stock.. if you look at recent times, low 80+ sen has been a good support level. then slowly inch up closer to results... post result, come back down. cycle repeats.
granted, the results so far has showed major turnaround already .. and the next rerating catalyst will come from the company saying it started mass production for its new product.. and selling big time to the big brand. then.. got chance to see RM1. wait and see ba.

1 month ago

abc333

macam kambing

2 weeks ago

Post a Comment